🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Egypt / NCT07237763
Active, not recruiting Not applicable

Assessment of the Efficacy of Topical Ketoconazole 2% Cream in Comparison With Topical Retinoids in the Treatment of Mild Comedonal and Papulopustular Acne

NCT07237763 · tracked via the Priya Life Science Egypt tracker
Phase
Not applicable
Started
2024-01-15
Last updated
2025-11-20

Condition(s) studied

Acne

Investigational drug(s) / intervention(s)

advised to apply topical ketoconazole 2% cream twice daily on the whole face.topical adapalene to the face

advised to apply topical ketoconazole 2% cream twice daily on the whole face.: ketoconazole will be applied twice per day on the face for 12 weeks

topical adapalene to the face: will be advised to apply topical adapalene cream once daily at night on the whole face except sensitive areas for a period of 12 weeks

Study summary

objective: is to assess the efficacy of topical ketoconazole 2% cream in comparison with topical retinoid in the treatment of mild comedonal and papulopustular acne to determine if ketoconazole can be an alternative to topical retinoid with less side effects and more compliance.

Patients and methods: 52 patients with mild comedonal and papulopustular acne will be randomized into 2 groups and instructed to apply randomly either topical KTZ 2% cream or topical retinoid cream for a period of 12 weeks. Evaluation of response will be done by a blinded investigator

Eligibility

Sex
FEMALE
Min age
18 Years
Max age
50 Years
Healthy volunteers
No
Inclusion Criteria: * Patients with mild comedonal or papulopustular acne with a GEA score from 1-2 on the face. * Both sexes. * Age: adolescents and adults. * Skin type 3 and 4. Exclusion Criteria: * • Patients using, will use during the study, or discontinued less than 4 weeks before study baseline, prescribed or over-the counter topical therapies for the treatment of acne. * Patients using, will use during the study, or discontinued less than 4 weeks before study baseline, any facial procedures such as chemical peel, laser treatment or depilation in area of treatment application (except eyebrow shaping). * Patients with outdoor occupation, exposed to sun and heat. * Patients using, will use during study any cosmoceuticals. * Patients using, will use during the study, or discontinued less than 12 weeks before study baseline, systemic therapies for the treatment of acne or any other systemic treatments. * Patients with other special types of acne or conditions presenting with acne/acneiform eruption. * Irregular menstrual cycles or clinically suspected polycystic ovarian syndrome. * Patients with other facial rashes preventing the accurate assessment. * Known or suspected allergy to ingredients. * Pregnancy or lactation.

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
Cairo university Cairo Egypt

More Cairo University trials in Egypt

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07237763 on ClinicalTrials.gov ↗ ← All trials in Egypt